title: [Aminoglutethimide and cancer of the prostate].
abstract: Aminoglutethimide (AG) is a drug that inhibits several steps of steroidogenesis; it is used in post-menopausal advanced breast cancer. More recently it has been proposed as a hormone therapy in prostatic cancer. Clinical studies involving patients resistant to orchidectomy and estrogens have generally given poor objective results and a frequent subjective response. It is too early to predict the interest of AG in the hormone therapy of prostate cancer since the studies are too few and since it has been used very late in the evolution of cancer.
mesh_terms: D000311:Adrenal Glands / Q000378:metabolism; D000616:Aminoglutethimide / Q000378:metabolism / Q000627:therapeutic use*; D000728:Androgens / Q000378:metabolism; D004341:Drug Evaluation; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D000728:Androgens; D000616:Aminoglutethimide
vernacular_title: Aminoglutéthimide (AG) et cancer de la prostate.